ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells

Nianli Liu1,2, Zhiyuan Wu1,2, Aoxing Chen1,2

  • 1Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Insights

ISG12a enhances cancer cell death induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). This protein interacts with NR4A1, promoting apoptosis and potentially overcoming TRAIL resistance in cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Mechanisms

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise for cancer therapy by selectively inducing apoptosis in cancer cells.
  • Clinical applications of TRAIL agonists are limited by a lack of predictive biomarkers for patient response and mechanisms of cancer cell resistance.
  • Previous research identified ISG12a as a potential biomarker that enhances TRAIL-induced apoptosis.

Purpose of the Study:

  • To elucidate the downstream mechanism by which ISG12a augments TRAIL-induced apoptosis.
  • To investigate the interaction between ISG12a and its downstream partners in the context of TRAIL signaling.
  • To explore the role of ISG12a and its interacting proteins in mediating TRAIL sensitivity and resistance in hepatoma cells.

Main Methods:

  • Subcellular localization studies of ISG12a.
  • Analysis of the intrinsic apoptotic pathway activation.
  • Co-immunoprecipitation to identify interacting proteins.
  • NR4A1 translocation assays and functional studies.
  • NF-κB and Jun N-terminal kinase signaling pathway analysis.
  • Gene knockdown experiments to assess functional significance.

Main Results:

  • ISG12a localizes to mitochondria and the nucleus, enhancing TRAIL-induced apoptosis via the intrinsic pathway.
  • ISG12a interacts with NR4A1, promoting its translocation from the nucleus to the cytoplasm.
  • Cytoplasmic NR4A1 targets mitochondria, induces Bcl2 conformational changes, and exposes the BH3 domain.
  • TRAIL induces NR4A1 expression via NF-κB activation in TRAIL-resistant cells, and NR4A1 knockdown overcomes this resistance.
  • TRAIL activates Jun N-terminal kinases in TRAIL-sensitive cells.

Conclusions:

  • ISG12a and NR4A1 are key mediators of TRAIL-induced apoptosis in hepatoma cells.
  • The ISG12a-NR4A1 interaction and subsequent NR4A1 cytoplasmic translocation are critical for augmenting TRAIL sensitivity.
  • Understanding these mechanisms provides insights into overcoming TRAIL resistance and developing targeted cancer therapies.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.4K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
9.0K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.6K